![]() |
Volumn 34, Issue 1-3, 2008, Pages 52-55
|
Low doses of cholestyramine in the treatment of hyperthyroidism
|
Author keywords
Anion exchange resins; Cholestyramine; Graves disease; Hyperthyroidism; Treatment outcome
|
Indexed keywords
COLESTYRAMINE;
LIOTHYRONINE;
PROPRANOLOL;
THIAMAZOLE;
THYROID HORMONE;
THYROXINE;
ANTITHYROID AGENT;
PLACEBO;
ADULT;
ARTICLE;
BLOATING;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG TOLERABILITY;
ENTEROHEPATIC CIRCULATION;
EUTHYROIDISM;
FEMALE;
FLATULENCE;
GRAVES DISEASE;
HUMAN;
LIOTHYRONINE BLOOD LEVEL;
LOW DRUG DOSE;
MALE;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
THYROTOXICOSIS;
THYROXINE BLOOD LEVEL;
TREATMENT RESPONSE;
DOSE RESPONSE;
HYPERTHYROIDISM;
MIDDLE AGED;
ADULT;
ANTITHYROID AGENTS;
CHOLESTYRAMINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
FEMALE;
GRAVES DISEASE;
HUMANS;
HYPERTHYROIDISM;
MALE;
METHIMAZOLE;
MIDDLE AGED;
PLACEBOS;
PROPRANOLOL;
YOUNG ADULT;
|
EID: 65449131693
PISSN: 1355008X
EISSN: 15590100
Source Type: Journal
DOI: 10.1007/s12020-008-9107-5 Document Type: Article |
Times cited : (40)
|
References (16)
|